EU–UKRAINE PHARMA DIALOGUE
Save the Date! Webinar 1: Pharma Rules 2027
December 03
Online (Zoom)

Save the Date! Join IMPACTA LAW for a webinar co-organised with international law firms Sidley and Hogan Lovells.
Ukraine is preparing for a major overhaul of its pharmaceutical regulatory framework, while the European Union is revising its own legislation. How will these parallel reforms affect international pharmaceutical companies operating in Ukraine and Ukrainian manufacturers seeking access to the EU market? What new requirements, regulatory risks and transition periods should businesses be preparing for today?
We go beyond a traditional overview of legislative changes. The discussion will focus on the gaps between current and upcoming EU rules and Ukraine’s regulatory reform, their implications for market access, and the practical decisions businesses will need to make. By bringing together Ukrainian and international legal expertise alongside regulators’ perspectives, we aim not only to explain the new rules but also to help companies prepare for their implementation.
Preliminary agenda
Opening: EU–Ukraine regulatory convergence
IMPACTA LAWKeynote: the future of EU pharma
European Commission, DG COMPI. Directive 2001/83/EC: the EU architecture today
SidleyII. The EU pharma package: what replaces the Directive
Hogan LovellsIII. Ukraine's view: implementing Law No. 2469-IX
Ministry of Health of UkraineIV. Panel: business implications and Q&A
DG COMP, Sidley, Hogan Lovells, Ministry of Health; moderated by IMPACTA LAW